1. Introduction to the Special Issue on “The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update”

Articles in Press, Corrected Proof, Available Online from 19 September 2021

Melanie Y. Bertram; Tessa Tan Torres Edejer

• View Article
• PDF 448.65 K

2. Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE

Articles in Press, Corrected Proof, Available Online from 20 January 2021

10.34172/ijhpm.2020.244

Melanie Y. Bertram; Jeremy A. Lauer; Karin Stenberg; Tessa Tan Torres Edejer

• View Article
• PDF 470.04 K

3. Priority Setting in HIV, Tuberculosis, and Malaria – New Cost-Effectiveness Results From WHO-CHOICE

Articles in Press, Corrected Proof, Available Online from 03 January 2021

10.34172/ijhpm.2020.251

Ambinintsoa H. Ralaidovy; Jeremy Addison Lauer; Carel Pretorius; Olivier JT Briët; Edith Patouillard

• View Article
• PDF 949.22 K

4. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis

Articles in Press, Corrected Proof, Available Online from 07 June 2021

10.34172/ijhpm.2021.37

Melanie Y. Bertram; Daniel Chisholm; Rory Watts; Temo Waqanivalu; Vinayak Prasad; Cherian Varghese

• View Article
• PDF 767.75 K

5. How Useful Are Early Economic Models?; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling”

Volume 9, Issue 5, May 2020, Pages 215-217

10.15171/ijhpm.2019.119

James Love-Koh

• View Article
• PDF 389.14 K

6. Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA; Comment on “Ethics in HTA: Examining the ‘Need for Expansion’”

Volume 8, Issue 12, December 2019, Pages 732-733

10.15171/ijhpm.2019.73

Anthony J. Culyer

• View Article
• PDF 321.12 K

7. Moving Towards Accountability for Reasonableness – A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study

Volume 8, Issue 7, July 2019, Pages 424-443

10.15171/ijhpm.2019.24

Monika Wagner; Dima Samaha; Roman Casciano; Matthew Brougham; Payam Abrishami; Charles Petrie; Bernard Avouac; Lorenzo Mantovani; Antonio Sarría-Santamera; Paul Kind; Michael Schlander; Michele Tringali

• View Article
• PDF 803.08 K

8. Evidence-Informed Deliberative Processes – Early Dialogue, Broad Focus and Relevance: A Response to Recent Commentaries

Volume 7, Issue 1, January 2018, Pages 96-97

10.15171/ijhpm.2017.88

Maarten P. Jansen; Rob Baltussen; Evelinn Mikkelsen; Noor Tromp; Jan Hontelez; Leon Bijlmakers; Gert Jan van der Wilt

• View Article
• PDF 316.56 K

9. Priority Setting for Universal Health Coverage: We Need to Focus Both on Substance and on Process; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, not Just More Evidence on Cost-Effectiveness”

Volume 6, Issue 10, October 2017, Pages 601-603

10.15171/ijhpm.2017.06

Jeremy A. Lauer; Dheepa Rajan; Melanie Y. Bertram

• View Article
• PDF 339.74 K

10. Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness

Volume 5, Issue 11, November 2016, Pages 615-618

10.15171/ijhpm.2016.83

Rob Baltussen; Maarten P. Jansen; Evelinn Mikkelsen; Noor Tromp; Jan Hontelez; Leon Bijlmakers; Gert Jan Van der Wilt

• View Article
• PDF 431.67 K

11. Incorporating Cost-Effectiveness Data in a Fair Process for Priority Setting Efforts; Comment on “Use of Cost-Effectiveness Data in Priority Setting Decisions: Experiences from the National Guidelines for Heart Diseases in Sweden”

Volume 4, Issue 7, July 2015, Pages 483-485

10.15171/ijhpm.2015.81

Sitaporn Youngkong

• View Article
• PDF 359.45 K